Clifford G. Tepper

7.9k citations

102 papers · 6.2k indexed · 2 hit papers · h-index 41

Molecular Biology top 1%
Cancer Research top 0.5%
Pulmonary and Respiratory Medicine top 1%
Oncology top 2%
Immunology top 5%

Co-authors: Hsing-Jien Kung Ralph W. deVere White Michael F. Seldin Xu-Bao Shi Lingru Xue Arul M. Chinnaiyan Frank Kischkel Peter H. Krammer
Topics: Prostate Cancer Treatment and Research (21 papers)Ubiquitin and proteasome pathways (15 papers)Viral-associated cancers and disorders (14 papers)
Cited by: Cancer Research Molecular Biology Oncology
Journals: Science Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States China United Kingdom

In The Last Decade

Clifford G. Tepper

100 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion–Resistant Growth

2009 698 citations Zhiyong Guo, Xi Yang et al. Cancer Research profile →
FADD/MORT1 Is a Common Mediator of CD95 (Fas/APO-1) and Tumor Necrosis Factor Receptor-induced Apoptosis

1996 653 citations Arul M. Chinnaiyan, Clifford G. Tepper et al. profile →

Peers

Countries citing papers authored by Clifford G. Tepper

Since Specialization

Citations

This map shows the geographic impact of Clifford G. Tepper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clifford G. Tepper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clifford G. Tepper more than expected).

Fields of papers citing papers by Clifford G. Tepper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clifford G. Tepper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clifford G. Tepper. The network helps show where Clifford G. Tepper may publish in the future.

Co-authorship network of co-authors of Clifford G. Tepper

This figure shows the co-authorship network connecting the top 25 collaborators of Clifford G. Tepper. A scholar is included among the top collaborators of Clifford G. Tepper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clifford G. Tepper. Clifford G. Tepper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Androgen receptor-dependent regulation of metabolism in high grade bladder cancer cells 2023 ·Scientific Reports ·(unknown),(unknown),(unknown),(unknown),(unknown),Clifford G. Tepper,Gino Cortopassi,P. Ghosh,Maria Mudryj	4
2	Multiomic analysis for optimization of combined focal and immunotherapy protocols in murine pancreatic cancer 2022 ·Theranostics ·James Wang,Brett Z. Fite,Aris J. Kare,Bo Wu,Marina N. Raie,Spencer K. Tumbale,Nisi Zhang,Ryan R. Davis,Clifford G. Tepper,Sharon Aviran,Aaron M. Newman,Daniel A. King,Katherine W. Ferrara	5
3	A Syngeneic ErbB2 Mammary Cancer Model for Preclinical Immunotherapy Trials 2019 ·Journal of Mammary Gland Biology and Neoplasia ·(unknown),(unknown),Clifford G. Tepper,Ryan R. Davis,Matthew T. Silvestrini,(unknown),Colleen Sweeney,Alexander D. Borowsky	8
4	High frequency of the PNPLA3 rs738409 [G] single‐nucleotide polymorphism in Hmong individuals as a potential basis for a predisposition to chronic liver disease 2018 ·Cancer ·Clifford G. Tepper,Julie Dang,Susan L. Stewart,(unknown),(unknown),(unknown),Ryan R. Davis,Doan Y Dao,Jeffrey P. Gregg,Natalie J. Török,Moon S. Chen	19
5	Oncolytic Reactivation of KSHV as a Therapeutic Approach for Primary Effusion Lymphoma 2017 ·Molecular Cancer Therapeutics ·Feng Zhou,Michiko Shimoda,(unknown),Yuanzhi Lyu,Khiem A. Tran,Guochun Jiang,Kazushi Nakano,Ryan R. Davis,Clifford G. Tepper,Emanual Maverakis,Mel Campbell,Yuanpei Li,Satya Dandekar,Yoshihiro Izumiya	29
6	The Phosphatidylinositol 3-Kinase Pathway as a Potential Therapeutic Target in Bladder Cancer 2017 ·Clinical Cancer Research ·Shuxiong Zeng,Yanjun Zhu,Ai-Hong Ma,Weimin Yu,Hongyong Zhang,Tzu‐yin Lin,Wei Shi,Clifford G. Tepper,Paul T. Henderson,Susan Airhart,(unknown),(unknown),Ralph W. deVere White,Chong-xian Pan	44
7	Microdose-Induced Drug–DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice 2016 ·Molecular Cancer Therapeutics ·Maike Zimmermann,(unknown),Hongyong Zhang,(unknown),Michael Malfatti,Kurt Haack,Ted Ognibene,Hongyuan Yang,Susan Airhart,Kenneth W. Turteltaub,George D. Cimino,Clifford G. Tepper,Alexandra Drakaki,Karim Chamie,Ralph de Vere White,Chong‐Xian Pan,Paul T. Henderson	22
8	miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src 2015 ·Cancer Research ·Xu-Bao Shi,Ai-Hong Ma,Lingru Xue,Meimei Li,Hao G. Nguyen,Joy C. Yang,Clifford G. Tepper,Regina Gandour‐Edwards,Christopher P. Evans,Hsing-Jien Kung,(unknown)	61
9	The chromatin modification by SUMO-2/3 but not SUMO-1 prevents the epigenetic activation of key immune-related genes during Kaposi’s sarcoma associated herpesvirus reactivation 2013 ·BMC Genomics ·Pei‐Ching Chang,(unknown),Mel Campbell,(unknown),(unknown),Ting-Yu Chang,(unknown),Yi-Wei Lee,Chiu-Lien Hung,(unknown),Clifford G. Tepper,Wen‐Ping Hsieh,Hsei-Wei Wang,Chuan-Yi Tang,Wen‐Ching Wang,Hsing-Jien Kung	28
10	Nrdp1-Mediated Regulation of ErbB3 Expression by the Androgen Receptor in Androgen-Dependent but not Castrate-Resistant Prostate Cancer Cells 2010 ·Cancer Research ·(unknown),Salma Siddiqui,Swagata Bose,Benjamin A. Mooso,(unknown),Roble Bedolla,Ruth L. Vinall,Clifford G. Tepper,Regina Gandour‐Edwards,(unknown),(unknown),Javed Siddiqui,Arul M. Chinnaiyan,Rohit Mehra,Ralph W. deVere White,Kermit L. Carraway,P. Ghosh	48
11	ANCCA/ATAD2 Overexpression Identifies Breast Cancer Patients with Poor Prognosis, Acting to Drive Proliferation and Survival of Triple-Negative Cells through Control of B-Myb and EZH2 2010 ·Cancer Research ·Ekaterina Kalashnikova,Alexey S. Revenko,Abigael T. Gemo,Nicolas P. Andrews,Clifford G. Tepper,June X. Zou,Robert D. Cardiff,Alexander D. Borowsky,Hong-Wu Chen	134
12	A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion–Resistant Growthbreakdown → 2009 ·Cancer Research ·Zhiyong Guo,Xi Yang,Feng Sun,Richeng Jiang,Douglas E. Linn,Hege Chen,Hegang Chen,Xiangtian Kong,Jonathan Melamed,Clifford G. Tepper,Hsing-Jien Kung,Angela Brodie,Joanne Edwards,Yun Qiu	698
13	Microarray analysis reveals potential target genes of NF‐κB2/p52 in LNCaP prostate cancer cells 2009 ·The Prostate ·Nagalakshmi Nadiminty,(unknown),Clifford G. Tepper,Allen C. Gao	27
14	Regulation of Id1 Expression by Src: Implications for Targeting of the Bone Morphogenetic Protein Pathway in Cancer 2008 ·Cancer Research ·Oliver Gautschi,Clifford G. Tepper,Phillip R. Purnell,Yoshihiro Izumiya,Christopher P. Evans,Tim P. Green,Pierre Y. Desprez,Primo N. Lara,David R. Gandara,Philip C. Mack,Hsing-Jien Kung	67
15	microRNAs and prostate cancer 2008 ·Journal of Cellular and Molecular Medicine ·Xu‐Bao Shi,Clifford G. Tepper,Ralph W. deVere White	61
16	An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells 2007 ·Proceedings of the National Academy of Sciences ·Xu-Bao Shi,Lingru Xue,Joy C. Yang,Ai-Hong Ma,Jianjun Zhao,Xu Ma,Clifford G. Tepper,Christopher P. Evans,Hsing-Jien Kung,Ralph W. deVere White	390
17	Interleukin-17 Receptor-Like Gene Is a Novel Antiapoptotic Gene Highly Expressed in Androgen-Independent Prostate Cancer 2006 ·Cancer Research ·Zongbing You,Xu-Bao Shi,Grayson DuRaine,Dominik R. Haudenschild,Clifford G. Tepper,Su Hao Lo,Regina Gandour‐Edwards,(unknown),A. Hari Reddi	35
18	Inappropriate Activation of the Androgen Receptor by Nonsteroids: Involvement of the Src Kinase Pathway and Its Therapeutic Implications 2006 ·Cancer Research ·Sonal J. Desai,Ai-Hong Ma,Clifford G. Tepper,Hong-Wu Chen,Hsing-Jien Kung	49
19	The R273H p53 mutation can facilitate the androgen-independent growth of LNCaP by a mechanism that involves H2 relaxin and its cognate receptor LGR7 2006 ·Oncogene ·Ruth L. Vinall,Clifford G. Tepper,(unknown),Liping Xue,Regina Gandour‐Edwards,Ralph W. de Vere White	44
20	Syngeneic mouse mammary carcinoma cell lines: Two closely related cell lines with divergent metastatic behavior 2005 ·Clinical & Experimental Metastasis ·Alexander D. Borowsky,Ruria Namba,Lawrence J.T. Young,Kent W. Hunter,John Hodgson,Clifford G. Tepper,Erik T. McGoldrick,William J. Muller,Robert D. Cardiff,Jeffrey P. Gregg	158

About Clifford G. Tepper

Clifford G. Tepper is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 102 papers that have together received 6.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (21 papers), Ubiquitin and proteasome pathways (15 papers) and Viral-associated cancers and disorders (14 papers). The work is most often cited by research in Cancer Research (1.8k citations), Molecular Biology (4.0k citations) and Oncology (1.3k citations). Clifford G. Tepper has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Hsing-Jien Kung, Ralph W. deVere White, Michael F. Seldin, Xu-Bao Shi, Lingru Xue, Arul M. Chinnaiyan, Frank Kischkel, Peter H. Krammer, Karen O’Rourke and Vishva M. Dixit. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact